Ticagrelor is an antiplatelet therapy that is an alternative to aspirin for preventing recurrent stroke. Does ticagrelor produce better outcomes than aspirin? New research findings are summarized in a short video:

--> The SOCRATES Trial — NEJM: Quick Take Video Summary from The New England Journal of Medicine